Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy.

[1]  C. West,et al.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? , 2016, Cancer letters.

[2]  S. Wingert,et al.  DNA‐damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival , 2016, Stem cells.

[3]  P. Bagos,et al.  Emerging molecular networks common in ionizing radiation, immune and inflammatory responses by employing bioinformatics approaches. , 2015, Cancer letters.

[4]  C. Hellweg.  The Nuclear Factor κB pathway: A link to the immune system in the radiation response. , 2015, Cancer letters.

[5]  P. Townsend,et al.  The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where. , 2015, Pharmacology & therapeutics.

[6]  Liangfang Shen,et al.  The regulation of radiosensitivity by p53 and its acetylation. , 2015, Cancer letters.

[7]  Aglaia Pappa,et al.  Survival Fraction at 2 Gy and γH2AX Expression Kinetics in Peripheral Blood Lymphocytes From Cancer Patients: Relationship With Acute Radiation-Induced Toxicities. , 2015, International journal of radiation oncology, biology, physics.

[8]  J. Yarnold,et al.  DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy , 2014, Radiation and environmental biophysics.

[9]  K. Satyamoorthy,et al.  Influence of double-strand break repair on radiation therapy-induced acute skin reactions in breast cancer patients. , 2014, International journal of radiation oncology, biology, physics.

[10]  L. Stalpers,et al.  Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity. , 2014, International journal of radiation oncology, biology, physics.

[11]  J. Manfredi,et al.  Another fork in the road—life or death decisions by the tumour suppressor p53 , 2013, EMBO reports.

[12]  L. Distel,et al.  Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci , 2013, Radiation oncology.

[13]  Christophe Badie,et al.  Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  D. Fernandes,et al.  DNA double-strand break analysis by γ-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. , 2012, International journal of radiation oncology, biology, physics.

[15]  Jeremy E. Purvis,et al.  p53 Dynamics Control Cell Fate , 2012, Science.

[16]  Jun Li,et al.  A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities , 2012, PloS one.

[17]  M. Eble,et al.  In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy , 2012, International journal of radiation biology.

[18]  B. Vojnovic,et al.  In situ Biological Dose Mapping Estimates the Radiation Burden Delivered to ‘Spared’ Tissue between Synchrotron X-Ray Microbeam Radiotherapy Tracks , 2012, PloS one.

[19]  P. Lara,et al.  Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy , 2011, Radiation oncology.

[20]  Kai Rothkamm,et al.  Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  C. Parris,et al.  Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment , 2011, International journal of cancer.

[22]  V. Rotter,et al.  p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. , 2010, Carcinogenesis.

[23]  M. McKay,et al.  H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype , 2010, British Journal of Cancer.

[24]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  A. Georgakilas,et al.  Detection of Oxidative Clustered DNA Lesions in X-Irradiated Mouse Skin Tissues and Human MCF-7 Breast Cancer Cells , 2007, Radiation research.

[26]  O. Pereira-smith,et al.  p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. , 2006, Cancer research.

[27]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[28]  A. Mauviel,et al.  Comment modéliser les événements de la fibrose cutanée , 2006 .

[29]  Roger Owen,et al.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  J. Ring,et al.  Development and Evaluation of a Skin Organ Model for the Analysis of Radiation Effects , 2004, Strahlentherapie und Onkologie.

[31]  H. Rodemann,et al.  Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain® in human tumour and normal cells in vitro , 2003, International journal of radiation biology.

[32]  J. Dahm-Daphi,et al.  Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  G. Hortobagyi,et al.  Long-term complications associated with breast-conservation surgery and radiotherapy , 2002, Annals of Surgical Oncology.

[34]  C. West,et al.  Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  M. Flentje,et al.  In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients , 2002, International journal of radiation biology.

[36]  A. Fornace,et al.  The central region of Gadd45 is required for its interaction with p21/WAF1. , 2000, Experimental cell research.

[37]  J. Yarnold,et al.  Cellular radiosensitivity and complication risk after curative radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  J. Overgaard,et al.  Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone , 2000 .

[39]  M. Wannenmacher,et al.  Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  William F. Morgan,et al.  Genomic instability in Gadd45a-deficient mice , 1999, Nature Genetics.

[41]  J. Hendry,et al.  A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  A. Hart,et al.  Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. , 1998, International journal of radiation biology.

[43]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[44]  S M Bentzen,et al.  Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  S M Bentzen,et al.  Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. , 1994, International journal of radiation biology.

[46]  R. Slebos,et al.  Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.

[47]  R. Wurm,et al.  Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity , 1992, The Lancet.

[48]  H. Rodemann,et al.  Terminal differentiation of human fibroblasts is induced by radiation. , 1991, Scanning microscopy.

[49]  I. Turesson.  Individual variation and dose dependency in the progression rate of skin telangiectasia. , 1990, International journal of radiation oncology, biology, physics.

[50]  K. Dittmann,et al.  Human skin fibroblasts in vitro differentiate along a terminal cell lineage. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[51]  H. Forrester,et al.  Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. , 2015, Cancer letters.

[52]  D. Kletsas,et al.  The role of oxidative DNA damage in radiation induced bystander effect. , 2015, Cancer letters.

[53]  A. Georgakilas,et al.  Non-targeted radiation effects in vivo: a critical glance of the future in radiobiology. , 2015, Cancer letters.

[54]  J. Hendry,et al.  Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[55]  S. Tucker,et al.  Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. , 1995, International journal of radiation oncology, biology, physics.

[56]  W A Brock,et al.  Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. , 1993, International journal of radiation oncology, biology, physics.

[57]  F. Vicini,et al.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[58]  K. Dittmann,et al.  Selective enrichment and biochemical characterization of seven human skin fibroblasts cell types in vitro. , 1989, Experimental cell research.